KJ Muldoon, a 10-month-old baby diagnosed with a rare metabolic disease called CPS1 has been at the Children's Hospital of Philadelphia since birth and on Tuesday, he finally got to go home with his ...

Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using ...

In 2018, Chinese biophysicist He Jiankui engaged in gene-hacking experiments using CRISPR technology. He used it to edit the ...

Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR ...

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...

Researchers have used a personalised base-editing gene therapy to successfully treat an infant with carbamoyl-phosphate synthetase 1 (CPS1) deficiency, a rare and life-threatening inborn error of ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 gene-editing tool to spiders. Following the genetic modification, the spiders ...

The CRISPR market presents strong growth potential driven by rising demand for precision medicine, technological advancements, and increasing R&D investments. However, ethical concerns, regulatory ...

Designing a gRNA for CRISPR-Cas9 gene editing involves a precise process to ensure specificity and efficiency in targeting the desired DNA sequence. Here's an overview of how researchers design a ...